In this #RPTH Original Article, authors report observational data on #DOAC prescribing from 2017-2019 the most common errors include💊🔍: 🚨Dose related errors 🚨Improper drug selection 🚨DDIs 🚨Avoidance of ADRs Read here: rpthjournal.org/article/S2475-…

A retrospective review by Ochsner Health pharmacists found a high rate of inappropriate use of triple-antithrombotic therapy, especially treatment that exceeded 30 days and may have placed patients at increased risk for bleeding. doi.org/10.1093/ajhp/z…

Excited for Day 2 of #THSNA2024! Say hello to our #PGY2 Residents at: ✔️ 12:45 Booth #502 Alyssa George, PharmD, BCPS, CACP (Brigham and Women's Hospital) ✔️ 4:30 Booth #618 Taylor Robichaux, PharmD, BCPS (Johns Hopkins University) ✔️ 4:30 Booth #619 Poppy Wang (Henry Ford Health) #ACStewardship #AnticoagStewardship

Excited to present the results of our UFH calculator at #THSNA! It has been a great conference with the other #THM residents! #ACForum #ACstewardship

It's #WorldHemophiliaDay - to show our support, we're offering a 20% discount on ASHP's Non-Malignant Hematology Certificate designed for pharmacists to enhance their knowledge and skills in non-malignant hematology drug therapy and pharmacy practice. Use code NMH20 to save:

🛑Another negative trial for TXA in 🧠world 🩸 1. No utility in aSAH (removed from 2023 guidelines) 2. Now NO effect in ICH expansion compared to placebo when given within 2 hours of onset⁦ thelancet.com/journals/laneu…

Value of hospital anticoagulation stewardship programme: A systematic ... sciencedirect.com/science/articl… Virginia Silvari Keane 🇮🇹 🇮🇪 🇪🇺 continuing to lead the charge foe anticoagulation stewardship Cork University Hospitals

The factor Xa inhibitor reversal agent andexanet reduced expansion of intracerebral hemorrhages caused by factor Xa inhibitors but resulted in more thrombotic events than usual care. Read the full ANNEXA-I trial results: nej.md/3wAoERb

🚨🚨NEW #RPTH Illustrated Review🎨🖼️: DOACs for treatment of venous thrombosis: illustrated review of appropriate use C. Dini Khairani, MD, MMSc Antoine Bejjani, MD Ali Assi Nicole Azita Talasaz, PharmD Gregory Piazza Mary Cushman 🫀🧠🩸 Behnood Bikdeli Michelle Sholzberg READ: rpthjournal.org/article/S2475-…

#SickleCell is the most common monogenetic disease in the world. No better way to celebrate World Sickle Cell Day than to light up the iconic Johns Hopkins Medicine Dome red! Shout out to our Johns Hopkins Hematology #HemeDreamTeam who are tireless advocates for our #sicklecell patients!

🔊 Resource Alert: July Rapid Recap! Our free Rapid Recaps distill the top articles from the past month. Thank you authors Cooper Hamilton & Kelly Rudd, & editorial team Candace Bryant, Greg Hadlock, Tara Lech, Carlee O'Connor & Bishoy Ragheb! Download: bit.ly/3ybk64u

Reducing AC dose after a bleeding event may increase the risk of thrombotic events and does not significantly decrease incidences of bleeding ‼️🩸 #ACstewardship

How does Marc Carrier approach the choice between #DOAC and #LMWH for patients with #cancer assoc #VTE? Here are his key decision factors

We’re excited to share the latest October 2024 Rapid Recap, featuring a comprehensive write-up of the most impactful anticoagulation articles. This month's highlights include: 🔹 Utility of the Modified Ottawa Score to Identify Preferable Candidates for Extended Anticoagulation

Huge congratulations to Darren Triller, our Director of Strategic Initiatives, for not only reaching his fundraising goal but also crossing the finish line at the NYC Marathon this November! Darren ran in memory of Leschel, who tragically passed away from a pulmonary embolism

1/ FDA hearing on #andexanet alfa is tomorrow (21 Nov 2024). The documents contain some more data on thrombotic events that weren't published in ANNEXA-I. To be honest, reading through, I have found this data pretty shocking. A 🧵

📣 📣 JHH is recruiting for 1️⃣ PGY2 THM position🩸 for 2025-2026. Please reach out to schedule time to discuss at ASHP MCM PPS or Showcase, or elsewhere as needed. More info here: hopkinsmedicine.org/pharmacy/resid…

We’re excited to share our latest Rapid Recap (November 2024), featuring a comprehensive write-up of the most impactful anticoagulation articles from last month. Highlights include: 🔹 Anticoagulant therapy in pregnant women with mechanical and bioprosthetic heart valves 🔹

We are excited to be at the ASHP 2024 Midyear meeting. If you are attending, stop by the AC Forum table #313 and say hello to our team! Learn about our Thrombosis and Hemostasis Management (THM) residency program (Residency Showcase at 1pm today & twice tomorrow) and grab a pair

Last night, the AC Forum staff team, Board President Allison Burnett, and our amazing PGY2 Thrombosis and Hemostasis (THM) residents and program directors came together for a memorable dinner at ASHP. We are so grateful for the dedication and passion of this incredible group! 👉